Skip to main content

Research Repository

Advanced Search

Dr ANCA PORDEA's Outputs (3)

Encapsulation of copper phenanthroline within horse spleen apoferritin: characterisation, cytotoxic activity and ability to retain temozolomide (2024)
Journal Article
Cassioli, M. L., Fay, M., Turyanska, L., Bradshaw, T. D., Thomas, N. R., & Pordea, A. (2024). Encapsulation of copper phenanthroline within horse spleen apoferritin: characterisation, cytotoxic activity and ability to retain temozolomide. RSC Advances, 14(20), 14008-14016. https://doi.org/10.1039/d3ra07430g

Protein capsules are promising drug delivery vehicles for cancer research therapies. Apoferritin (AFt) is a self-assembling 12 nm diameter hollow nanocage with many desirable features for drug delivery, however, control of drug retention inside the p... Read More about Encapsulation of copper phenanthroline within horse spleen apoferritin: characterisation, cytotoxic activity and ability to retain temozolomide.

Oxidation of cadaverine by putrescine oxidase from Rhodococcus erythropolis (2021)
Journal Article
Anyanwu, V. E., Hall, S. J., Stephens, G., & Pordea, A. (2021). Oxidation of cadaverine by putrescine oxidase from Rhodococcus erythropolis. Journal of Chemical Technology and Biotechnology, 96(10), 2950-2955. https://doi.org/10.1002/jctb.6851

BACKGROUND
Putrescine oxidase (EC 1.4.3.10) is of interest for the microbial production of unsubstituted platform nitrogen (N-)heterocycles, because it only requires inexpensive oxygen as co-substrate. Putrescine oxidase from Rhodococcus erythropoli... Read More about Oxidation of cadaverine by putrescine oxidase from Rhodococcus erythropolis.

Design of artificial metalloenzymes for the reduction of nicotinamide cofactors (2021)
Journal Article
Basle, M., Padley, H. A., Martins, F. L., Winkler, G. S., Jäger, C. M., & Pordea, A. (2021). Design of artificial metalloenzymes for the reduction of nicotinamide cofactors. Journal of Inorganic Biochemistry, 220, Article 111446. https://doi.org/10.1016/j.jinorgbio.2021.111446

Artificial metalloenzymes result from the insertion of a catalytically active metal complex into a biological scaffold, generally a protein devoid of other catalytic functionalities. As such, their design requires efforts to engineer substrate bindin... Read More about Design of artificial metalloenzymes for the reduction of nicotinamide cofactors.